Protara Therapeutics, Inc. — Director's Dealing 2020

Sep 14, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Protara Therapeutics, Inc. (TARA)
CIK: 0001359931
Period of Report: 2020-09-10

Reporting Person: Marshall Randall (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-09-10	Common Stock	S	239	$18.00	Disposed	588154	Direct